Synced daily from ClinicalTrials.gov via AACT. Last sync: .
11 Clazakizumab clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 7 indications (including Antibody-mediated Rejection & COVID-19) and 1,622 total planned enrollment. 1 Phase 3 Clazakizumab trial and 8 Phase 2 are listed. 1 Clazakizumab clinical trial is actively recruiting at 1 U.S. site across 1 state. Most recent activity: NCT05727384 (May 2026).
Where to Participate: All Clazakizumab Trial Sites in the U.S. (1 site across 1 state)
Every actively recruiting Clazakizumabtrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection
A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection
11 Clazakizumab clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants. 7 are marked completed.
Are Clazakizumab clinical trials recruiting in 2026?
Yes — 1 Clazakizumab trial is actively recruiting in 2026, with 1 U.S. site across 1 state. See the recruiting trials and the per-state site list further down this page.
What conditions is Clazakizumab being studied for?
Clazakizumab is being studied for Antibody-mediated Rejection, COVID-19, Transplant Glomerulopathy, Kidney Transplant; Complications, Frailty and 11 more. The trials are grouped by indication on this page.
What phase is Clazakizumab in?
Clazakizumab clinical trials span 1 Phase 3, 8 Phase 2. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
Who sponsors Clazakizumab clinical trials?
The lead sponsor across the most Clazakizumab trials is CSL Behring, with 8 additional lead sponsors listed in the data. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Clazakizumabas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.